225 related articles for article (PubMed ID: 10633052)
1. Low level of bacterial contamination of mist tents used in home treatment of cystic fibrosis patients.
Jakobsson B; Hjelte L; Nyström B
J Hosp Infect; 2000 Jan; 44(1):37-41. PubMed ID: 10633052
[TBL] [Abstract][Full Text] [Related]
2. Microbial contamination of nebulizers in the home treatment of cystic fibrosis.
Blau H; Mussaffi H; Mei Zahav M; Prais D; Livne M; Czitron BM; Cohen HA
Child Care Health Dev; 2007 Jul; 33(4):491-5. PubMed ID: 17584406
[TBL] [Abstract][Full Text] [Related]
3. Low bacterial contamination of nebulizers in home treatment of cystic fibrosis patients.
Jakobsson BM; Onnered AB; Hjelte L; Nyström B
J Hosp Infect; 1997 Jul; 36(3):201-7. PubMed ID: 9253701
[TBL] [Abstract][Full Text] [Related]
4. A day in the life of a nebulizer: surveillance for bacterial growth in nebulizer equipment of children with cystic fibrosis in the hospital setting.
O'Malley CA; VandenBranden SL; Zheng XT; Polito AM; McColley SA
Respir Care; 2007 Mar; 52(3):258-62. PubMed ID: 17328823
[TBL] [Abstract][Full Text] [Related]
5. Impact of hypochlorite-based disinfection on bacterial contamination of cystic fibrosis patients' home-nebulisers.
Reychler G; Leonard A; Van Ossel C; Godding V; Gigi J; Simon A; Lebecque P
J Hosp Infect; 2009 Aug; 72(4):351-7. PubMed ID: 19596489
[TBL] [Abstract][Full Text] [Related]
6. In vitro evaluation of efficacy of 5 methods of disinfection on mouthpieces and facemasks contaminated by strains of cystic fibrosis patients.
Reychler G; Aarab K; Van Ossel C; Gigi J; Simon A; Leal T; Lebecque P
J Cyst Fibros; 2005 Sep; 4(3):183-7. PubMed ID: 16046195
[TBL] [Abstract][Full Text] [Related]
7. Microbiologic contamination study of nebulizers after aerosol therapy in patients with cystic fibrosis.
Vassal S; Taamma R; Marty N; Sardet A; d'athis P; Brémont F; Dalphin ML; Plésiat P; Rault G; Thubert J; Dominique S; Lemeland JF; Derelle J; Blech MF; Roussey M; Perrin M; Sautegeau A
Am J Infect Control; 2000 Oct; 28(5):347-51. PubMed ID: 11029133
[TBL] [Abstract][Full Text] [Related]
8. Bacterial contamination in the environment of hospitalised children with cystic fibrosis.
Ferroni A; Werkhauser-Bertrand A; Le Bourgeois M; Beauvais R; Vrielynck S; Durand C; Lenoir G; Berche P; Sermet-Gaudelus I
J Cyst Fibros; 2008 Nov; 7(6):477-82. PubMed ID: 18550452
[TBL] [Abstract][Full Text] [Related]
9. An evaluation of different steam disinfection protocols for cystic fibrosis nebulizers.
Hohenwarter K; Prammer W; Aichinger W; Reychler G
J Cyst Fibros; 2016 Jan; 15(1):78-84. PubMed ID: 26233897
[TBL] [Abstract][Full Text] [Related]
10. Microbiological contamination of nebulizers used by cystic fibrosis patients: an underestimated problem.
Riquena B; Monte LFV; Lopes AJ; Silva-Filho LVRFD; Damaceno N; Aquino EDS; Marostica PJC; Ribeiro JD
J Bras Pneumol; 2019 May; 45(3):e20170351. PubMed ID: 31166553
[TBL] [Abstract][Full Text] [Related]
11. [Practical problems in supply and use of ultrasonic nebulizers at home for aerosol treatment of cystic fibrosis].
Sandroni A; Tosi M; Mastella G
Pediatr Med Chir; 1992; 14(1):47-51. PubMed ID: 1579517
[TBL] [Abstract][Full Text] [Related]
12. Pseudomonas species contamination of cystic fibrosis patients' home inhalation equipment.
Pitchford KC; Corey M; Highsmith AK; Perlman R; Bannatyne R; Gold R; Levison H; Ford-Jones EL
J Pediatr; 1987 Aug; 111(2):212-6. PubMed ID: 3612391
[TBL] [Abstract][Full Text] [Related]
13. Soluble squalamine tablets for the rapid disinfection of home nebulizers of cystic fibrosis patients.
Djouhri-Bouktab L; Alhanout K; Andrieu V; Stremler N; Dubus JC; Raoult D; Rolain JM; Brunel JM
J Cyst Fibros; 2012 Dec; 11(6):555-9. PubMed ID: 22727722
[TBL] [Abstract][Full Text] [Related]
14. Bacterial contamination of spacer devices used by asthmatic children.
Cohen HA; Cohen Z; Pomeranz AS; Czitron B; Kahan E
J Asthma; 2005 Apr; 42(3):169-72. PubMed ID: 15962872
[TBL] [Abstract][Full Text] [Related]
15. Toys in a pediatric hospital: are they a bacterial source?
Avila-Aguero ML; German G; Paris MM; Herrera JF;
Am J Infect Control; 2004 Aug; 32(5):287-90. PubMed ID: 15292894
[TBL] [Abstract][Full Text] [Related]
16. Early aggressive eradication therapy for intermittent Pseudomonas aeruginosa airway colonization in cystic fibrosis patients: 15 years experience.
Hansen CR; Pressler T; Høiby N
J Cyst Fibros; 2008 Nov; 7(6):523-30. PubMed ID: 18693078
[TBL] [Abstract][Full Text] [Related]
17. Nebulizer use and maintenance by cystic fibrosis patients: a survey study.
Lester MK; Flume PA; Gray SL; Anderson D; Bowman CM
Respir Care; 2004 Dec; 49(12):1504-8. PubMed ID: 15571641
[TBL] [Abstract][Full Text] [Related]
18. [Survey of methods of cleaning, decontamination, disinfection and sterilization in dental health services in tropical areas].
Clapeau G; Decroix B; Bakayoko-Ly R; Varenne B; Dosso-Hien D; Decroix MO
Sante; 1997; 7(5):323-9. PubMed ID: 9480039
[TBL] [Abstract][Full Text] [Related]
19. Contamination of the nebulization systems used in the prophylaxis with amphotericin B nebulized in lung transplantation.
Monforte V; Román A; Gavaldà J; Bravo C; Rodriguez V; Ferrer A; Pahissa A; Morell F
Transplant Proc; 2005 Nov; 37(9):4056-8. PubMed ID: 16386625
[TBL] [Abstract][Full Text] [Related]
20. Frequency of contamination of single-patient-use nebulizers over time.
Weber DJ; Gergen MF; Sickbert-Bennett EE; Short KA; Lanza-Kaduce KE; Rutala WA
Infect Control Hosp Epidemiol; 2014 Dec; 35(12):1543-6. PubMed ID: 25419779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
